Cargando…

The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-Line Chemotherapy

BACKGROUND: Recent data have shown that right-sided colon cancer carries poorer prognosis compared to left-sided tumors. This study was aimed to evaluate the progression-free survival, overall survival of patients with metastatic colon cancer of right-sided versus left-sided primaries treated with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazarbashi, Shouki, Omar, Ayman T, Raddaoui, Leen, Badran, Ahmed, Alzahrani, Ahmed, Aljubran, Ali, Elhassan, Tusneem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982651/ https://www.ncbi.nlm.nih.gov/pubmed/31653131 http://dx.doi.org/10.31557/APJCP.2019.20.10.2891

Ejemplares similares

Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer
por: Elshenawy, Mahmoud A., et al.
Publicado: (2020)

Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II Trial
por: Bazarbashi, Shouki, et al.
Publicado: (2023)

Efficacy and Prognostic Factors of Sunitinib as First-Line Therapy for Patients With Metastatic Renal Cell Carcinoma in an Arab Population
por: Badran, Ahmed, et al.
Publicado: (2020)

Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer
por: Bazarbashi, Shouki, et al.
Publicado: (2015)

Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
por: Bazarbashi, Shouki, et al.
Publicado: (2022)

Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study
por: Aljubran, Ali, et al.
Publicado: (2019)

Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre
por: Bazarbashi, Shouki, et al.
Publicado: (2023)

Outcomes and Prognostic Factors of Metastatic Gastric Cancer: A Single-Center Experience
por: Aseafan, Mohamed, et al.
Publicado: (2022)

Characteristics and outcomes of small bowel adenocarcinoma: 14 years of experience at a single tertiary hospital in Saudi Arabia
por: Alshamsan, Bader, et al.
Publicado: (2023)

Utilization and cost of electronic resources in adult cancer center
por: Maraiki, Fatma, et al.
Publicado: (2018)

“Sidedness” as a standard hypernym for “right” and “left” in anatomy
por: Amarin, Justin Z., et al.
Publicado: (2021)

Adult-Type Ovarian Granulosa Cell Tumour: Treatment Outcomes From a Single-Institution Experience
por: Alhusaini, Hamed, et al.
Publicado: (2022)

Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer
por: Alshamsan, Bader, et al.
Publicado: (2022)

The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer
por: Kim, Seung Tae, et al.
Publicado: (2017)

The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancer
por: Kim, Seung Tae, et al.
Publicado: (2018)

Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients
por: You, Xia-Hong, et al.
Publicado: (2019)

The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal Cancer
por: Yoon, Sang Eun, et al.
Publicado: (2019)

Recurrence and progression in nonmuscle invasive transitional cell carcinoma of urinary bladder treated with intravesical Bacillus Calmette–Guerin: A single center experience and analysis of prognostic factors
por: Bazarbashi, Shouki N., et al.
Publicado: (2016)

Impact of sidedness of colorectal cancer on tumor immunity
por: Takasu, Chie, et al.
Publicado: (2020)

Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia
por: Alghamdi, Mohammed, et al.
Publicado: (2022)

Why local guidelines?
por: Bazarbashi, Shouki
Publicado: (2011)

Clinicopathological significance and prognostic role of LAG3 + tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness
por: Tavana, Shirin, et al.
Publicado: (2023)

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Management of Peritoneal Sarcomatosis: A Preliminary Single-Center Experience from Saudi Arabia
por: Abu-Zaid, Ahmed, et al.
Publicado: (2016)

Prognostic Impact of Tumor Status, Nodal Status and Tumor Sidedness in Metastatic Colon Cancer
por: Mukkamalla, Shiva Kumar R, et al.
Publicado: (2020)

P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE.
por: Haroon, Alfadil, et al.
Publicado: (2023)

Saudi Oncology Society clinical management guideline series: Colorectal cancer 2014
por: Bazarbashi, Shouki N., et al.
Publicado: (2014)

Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306)
por: Modest, Dominik Paul, et al.
Publicado: (2017)

Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies
por: Boeckx, N., et al.
Publicado: (2017)

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer
por: Loupakis, Fotios, et al.
Publicado: (2015)

Saudi Oncology Society clinical management guidelines development
por: Bazarbashi, Shouki N.
Publicado: (2014)

Plant cell polarity: The many facets of sidedness
por: Dong, Juan, et al.
Publicado: (2023)

Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer
por: van Nassau, Sietske C., et al.
Publicado: (2021)

Saudi Oncology Society clinical management guideline series: Anal canal cancer 2014
por: Bazarbashi, Shouki N., et al.
Publicado: (2014)

Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis
por: Bylsma, Lauren C., et al.
Publicado: (2019)

Bevacizumab in metastatic colorectal cancer in a real-life setting – toxicity profile, survival outcomes, and impact of tumor sidedness
por: Chibani, Hind, et al.
Publicado: (2022)

Saudi Oncology Society clinical management guideline series: Pancreatic cancer 2014
por: Rahal, Mohammed M., et al.
Publicado: (2014)

Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base
por: Mukkamalla, Shiva Kumar R., et al.
Publicado: (2020)

Colon Cancer Sidedness, Presentation, and Survival at Different Stages
por: Ulanja, Mark B., et al.
Publicado: (2019)

Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis
por: van der Kruijssen, Dave E. W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ie663icpa1lpp5l80t1m2ig05h